We have located links that may give you full text access.
High patient satisfaction with significant improvement in knee function and pain relief after mid-term follow-up in patients with isolated patellofemoral inlay arthroplasty.
PURPOSE: To prospectively evaluate the clinical and radiographic outcomes and survivorship at 2 and 5 years after isolated contemporary patellofemoral inlay arthroplasty.
METHODS: Thirty-four patients were prospectively enrolled in the study and were evaluated preoperatively and at 2 and 5 years postoperatively. Clinical outcomes included the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score and the visual analogue scale (VAS) for pain. Kellgren-Lawrence grading was used to assess the progression of tibiofemoral osteoarthritis and the Caton-Deschamps Index to determine patellar height. A Kaplan-Meier survival analysis was used to investigate the implant survivorship. Preoperative patient characteristics were compared among failures and success to determine potential risk factors and patient satisfaction was rated postoperatively.
RESULTS: Five of the 34 patients were lost to follow-up resulting in a final follow-up rate of 86%. The total WOMAC subscores of pain and function and the VAS Pain improved significantly at 2- and 5-years, with no significant difference between the two time points. The WOMAC stiffness subscale reached significant improvement at 2-year follow-up alone. No significant progressions of tibiofemoral arthritis or changes in patellar height were observed. A total of six patients (17.1%) failed leaving a survival rate of 91% after 2 years and 83% after 5 years. The main cause for postoperative failure was persistent knee pain; however, no significant preoperative risk factor in patient characteristics could be identified.
CONCLUSION: Patellofemoral inlay arthroplasty shows high patient satisfaction with significant improvement in knee function and pain relief after mid-term follow-up with no radiographic progression of tibiofemoral OA.
LEVEL OF EVIDENCE: Prospective case series, Level III.
METHODS: Thirty-four patients were prospectively enrolled in the study and were evaluated preoperatively and at 2 and 5 years postoperatively. Clinical outcomes included the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score and the visual analogue scale (VAS) for pain. Kellgren-Lawrence grading was used to assess the progression of tibiofemoral osteoarthritis and the Caton-Deschamps Index to determine patellar height. A Kaplan-Meier survival analysis was used to investigate the implant survivorship. Preoperative patient characteristics were compared among failures and success to determine potential risk factors and patient satisfaction was rated postoperatively.
RESULTS: Five of the 34 patients were lost to follow-up resulting in a final follow-up rate of 86%. The total WOMAC subscores of pain and function and the VAS Pain improved significantly at 2- and 5-years, with no significant difference between the two time points. The WOMAC stiffness subscale reached significant improvement at 2-year follow-up alone. No significant progressions of tibiofemoral arthritis or changes in patellar height were observed. A total of six patients (17.1%) failed leaving a survival rate of 91% after 2 years and 83% after 5 years. The main cause for postoperative failure was persistent knee pain; however, no significant preoperative risk factor in patient characteristics could be identified.
CONCLUSION: Patellofemoral inlay arthroplasty shows high patient satisfaction with significant improvement in knee function and pain relief after mid-term follow-up with no radiographic progression of tibiofemoral OA.
LEVEL OF EVIDENCE: Prospective case series, Level III.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app